Health & Nutrition

bg
DOJ sues Tennessee, alleging it discriminates against transgender youth with new law

DOJ sues Tennessee, alleging it discriminates against transgender...

The Biden administration asked a judge to declare that a Tennessee law targeting...

bg
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds

Eli Lilly says obesity drug tirzepatide resulted in weight...

Eli Lilly plans to complete its application for FDA approval of tirzepatide in the...

bg
Merck results beat expectations despite a big drop in sales of Covid antiviral treatment

Merck results beat expectations despite a big drop in sales...

Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for...

bg
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says

Alzheimer's: Medicare will cover Leqembi for all patients...

Medicare has severely restricted access to the medication Leqembi, which costs $26,500...

bg
No prison yet for Elizabeth Holmes following last-ditch appeal

No prison yet for Elizabeth Holmes following last-ditch...

Theranos founder Elizabeth Holmes has appealed a judge's ruling that she report...

bg
Eli Lilly misses on earnings but raises full-year guidance

Eli Lilly misses on earnings but raises full-year guidance

The company reported adjusted earnings of $1.62, which missed analyst expectations...

bg
Dr. Greger’s Top Takeaways on Dietary Cholesterol, Fasting for Cancer, and Edibles

Dr. Greger’s Top Takeaways on Dietary Cholesterol, Fasting...

Every month, we publish around eight new videos, four Friday Favorites, eight blogs,...

bg
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says

Biogen isn't concerned about competing with Eli Lilly in...

Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs...

bg
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

FDA grants accelerated approval for Biogen ALS drug that...

The FDA's approval requires Biogen to further study its ALS drug tofersen to further...

bg
Illumina unveils plans to cut costs as it faces shrinking margins

Illumina unveils plans to cut costs as it faces shrinking...

The plans aim to reduce Illumina's annualized run rate expenses by more than $100...